Proactive Investors - Run By Investors For Investors

IXICO PLC to support late phase clinical research programme in Huntington's disease

IXICO PLC's (LON:IXI) senior vice president of corporate development John Hall speaks to Proactive London after announcing that they're to provide data analytics and neuroimaging services to a late-stage programme for people with the degenerative brain disorder Huntington's disease.

IXICO’s involvement will generate a further £500,000 in revenues.

Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full IXI profile View Profile

IXICO PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use